Fierce Biotech2d
Lundbeck ends subcutaneous migraine cohort after futility review, pivots to IV formulation
Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker ...
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...
Nature3mon
Intravenous versus subcutaneous darbepoetin alfa in hemodialysis patients
Subject to confirmation in larger trials, these differences in darbepoetin alfa dosing requirements might make intravenous administration more cost-efficient than the subcutaneous route.
Medscape3d
Subcutaneous Pembro on Par With IV Administration in Lung Cancer
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.
Contract Pharma6d
Merck Seeks FDA Approval for Subcutaneous Pembrolizumab
Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...
Pharmabiz4d
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...